Modeling individual variability in CD19 CAR-T therapy: An in vivo study with PBMC-humanized mice

被引：0
|
作者：
Lee, Won
Rose, Destanie
Keck, James G.
Yang, Jiwon
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3850
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3850
引用
收藏
页数：2
相关论文
共 50 条
  • [31] In Vivo PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Autologous and Allogeneic Chimeric Antigen Receptor T-Cell Immunotherapy
    Lee, Won
    Rose, Destanie
    Cheng, Mingshan
    Gustafson, Heather
    Gardner, Rebecca A.
    Keck, James G.
    Yang, Jiwon
    BLOOD, 2022, 140 : 10267 - 10268
  • [32] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2021, 138
  • [33] Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    BLOOD, 2024, 144 : 2819 - 2819
  • [34] Repeat Infusions of CD19 CAR-T Cells: Factors Associated with Response, CAR-T Cell In Vivo Expansion, and Progression-Free Survival
    Gauthier, Jordan
    Bezerra, Evandro Dantas
    Hirayama, Alexandre V.
    Fender, Barbara S.
    Vakil, Aesha
    Steinmetz, Rachel N.
    Chapuis, Aude G.
    Till, Brian G.
    Kiem, Hans-Peter
    Shadman, Mazyar
    Cassaday, Ryan D.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S267 - S268
  • [35] Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo
    Ye, Xiupeng
    Liu, Meijing
    Lv, Cuicui
    Li, Yeqiong
    Chen, Lan
    Zhang, Jin
    Mu, Juan
    Deng, Qi
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [36] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138
  • [37] CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review
    Andrew J. Portuguese
    Jordan Gauthier
    Scott S. Tykodi
    Evan T. Hall
    Alexandre V. Hirayama
    Cecilia C. S. Yeung
    Christopher D. Blosser
    Bone Marrow Transplantation, 2023, 58 : 353 - 359
  • [38] Genomic Drivers of Large B-Cell Lymphoma Resistance to CD19 CAR-T Therapy
    Jain, Michael D.
    Ziccheddu, Bachisio
    Coughlin, Caroline A.
    Faramand, Rawan
    Griswold, Anthony J.
    Reid, Kayla M.
    Landgren, Ola
    Locke, Frederick L.
    Maura, Francesco
    Davila, Marco L.
    Schatz, Jonathan H.
    BLOOD, 2021, 138
  • [39] CD19 CAR-T Cell Therapy Induced Immunotherapy Associated Interstitial Pneumonitis: A Case Report
    Sun, Zhuanyi
    Xie, Caiqin
    Liu, Hui
    Yuan, Xianggui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma
    Gong, Inna Y.
    Tran, Daisy
    Saibil, Samuel
    Laister, Rob C.
    Kuruvilla, John
    HEMASPHERE, 2024, 8 (08):
12345